DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Avience Biomedicals Limited — Investor Presentation

NSE 57 min ago·24 Jul 2026, 7:55 am

AVIENCE NSE

Avience Biomedicals Limited has released its investor presentation to the stock exchange. This document typically outlines the company's business strategy, financial performance, and future outlook for shareholders and the market.

For investors, this update is important as it provides transparency into the management's plans and helps assess the company's growth trajectory. It allows retail investors to evaluate the company's direction and operational progress.

Investors should look for details on revenue growth, new product launches, and expansion plans mentioned in the presentation. Monitoring the company's response to market trends will be key to understanding its future performance.